拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 4455人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1511741, encodeId=31181511e4159, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=BioLineRx宣布其CXCL4拮抗剂BL-8040与Keytruda联合治疗转移性胰腺癌的2b临床活性, objectType=article, longId=182514, objectId=bed218251491, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bed218251491, replyNumber=0, likeNumber=51, createdTime=2019-11-08, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bed218251491, moduleTitle=BioLineRx宣布其CXCL4拮抗剂BL-8040与Keytruda联合治疗转移性胰腺癌的2b临床活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bed218251491)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511740, encodeId=796f1511e408b, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究, objectType=article, longId=178845, objectId=88551e8845db, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88551e8845db, replyNumber=0, likeNumber=60, createdTime=2019-09-06, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88551e8845db, moduleTitle=头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88551e8845db)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511739, encodeId=91fb1511e39af, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Cell | 解惑！肿瘤坏死因子拮抗剂治疗不明原因肠炎为何经常无效？, objectType=article, longId=178833, objectId=93361e8833b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93361e8833b9, replyNumber=0, likeNumber=60, createdTime=2019-09-06, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93361e8833b9, moduleTitle=Cell | 解惑！肿瘤坏死因子拮抗剂治疗不明原因肠炎为何经常无效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93361e8833b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511738, encodeId=b5d21511e38ce, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Lancet：肌松拮抗剂与麻醉后肺部并发症：多中心前瞻性观察研究, objectType=article, longId=178508, objectId=d77e1e8508a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d77e1e8508a7, replyNumber=0, likeNumber=67, createdTime=2019-09-02, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d77e1e8508a7, moduleTitle=Lancet：肌松拮抗剂与麻醉后肺部并发症：多中心前瞻性观察研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d77e1e8508a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511737, encodeId=48dc1511e37ff, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Sci transl med：MDM2拮抗剂可克服黑色素瘤对CDK4/6抑制剂的耐药性, objectType=article, longId=178015, objectId=77ed1e8015f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77ed1e8015f9, replyNumber=0, likeNumber=51, createdTime=2019-08-22, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77ed1e8015f9, moduleTitle=Sci transl med：MDM2拮抗剂可克服黑色素瘤对CDK4/6抑制剂的耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=77ed1e8015f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511736, encodeId=bd961511e36be, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Stroke：亚洲房颤患者非维生素K拮抗剂口服抗凝剂与华法林疗效比较, objectType=article, longId=177976, objectId=51a71e797653, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51a71e797653, replyNumber=0, likeNumber=79, createdTime=2019-08-21, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51a71e797653, moduleTitle=Stroke：亚洲房颤患者非维生素K拮抗剂口服抗凝剂与华法林疗效比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51a71e797653)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511735, encodeId=e1b71511e35f3, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Sci transl med：GHSR1拮抗剂联合DRD1拮抗剂可改善AD病变, objectType=article, longId=177732, objectId=21201e77328c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21201e77328c, replyNumber=0, likeNumber=56, createdTime=2019-08-17, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21201e77328c, moduleTitle=Sci transl med：GHSR1拮抗剂联合DRD1拮抗剂可改善AD病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21201e77328c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511734, encodeId=7c361511e3409, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=卵巢储备功能低下高龄患者微刺激助孕失败后拮抗剂方案成功助孕１例, objectType=article, longId=177050, objectId=d54c1e7050a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d54c1e7050a3, replyNumber=0, likeNumber=78, createdTime=2019-08-08, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d54c1e7050a3, moduleTitle=卵巢储备功能低下高龄患者微刺激助孕失败后拮抗剂方案成功助孕１例, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d54c1e7050a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511733, encodeId=10861511e33e4, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Clin Gastroenterology H：早期启动肿瘤坏死因子拮抗剂治疗克罗恩病比晚期启动相比降低了成本, objectType=article, longId=175463, objectId=22bc1e546309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=22bc1e546309, replyNumber=0, likeNumber=45, createdTime=2019-07-16, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=22bc1e546309, moduleTitle=Clin Gastroenterology H：早期启动肿瘤坏死因子拮抗剂治疗克罗恩病比晚期启动相比降低了成本, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=22bc1e546309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511732, encodeId=6b221511e3268, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=NEJM：口服降钙素基因相关肽受体拮抗剂Rimegepant治疗偏头痛, objectType=article, longId=175197, objectId=babf1e519785, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=babf1e519785, replyNumber=0, likeNumber=62, createdTime=2019-07-12, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=babf1e519785, moduleTitle=NEJM：口服降钙素基因相关肽受体拮抗剂Rimegepant治疗偏头痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=babf1e519785)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511731, encodeId=592b1511e317a, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症, objectType=article, longId=167914, objectId=c16616e91458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c16616e91458, replyNumber=0, likeNumber=59, createdTime=2019-06-11, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c16616e91458, moduleTitle=Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c16616e91458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511730, encodeId=18a71511e30eb, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Blood：口服MDM2蛋白拮抗剂Idasanutlin用于真性红细胞增多症的疗效评估, objectType=article, longId=167795, objectId=d99916e79567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d99916e79567, replyNumber=0, likeNumber=74, createdTime=2019-06-08, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d99916e79567, moduleTitle=Blood：口服MDM2蛋白拮抗剂Idasanutlin用于真性红细胞增多症的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d99916e79567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511729, encodeId=048f1511e2970, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Neurology：β2AR激动剂/拮抗剂与帕金森病的相关性, objectType=article, longId=167138, objectId=f45116e138f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f45116e138f4, replyNumber=0, likeNumber=62, createdTime=2019-05-31, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f45116e138f4, moduleTitle=Neurology：β2AR激动剂/拮抗剂与帕金森病的相关性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f45116e138f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511728, encodeId=ee9c1511e2805, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=子宫内膜异位症相关疼痛：GnRH受体拮抗剂linzagolix的II期试验取得成功, objectType=article, longId=165448, objectId=640116544883, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=640116544883, replyNumber=0, likeNumber=58, createdTime=2019-05-07, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=640116544883, moduleTitle=子宫内膜异位症相关疼痛：GnRH受体拮抗剂linzagolix的II期试验取得成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=640116544883)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511727, encodeId=36fe1511e2712, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Bayer/Orion的非甾体雄激素受体拮抗剂darolutamide治疗前列腺癌获得FDA优先审查, objectType=article, longId=165296, objectId=373b1652964b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=373b1652964b, replyNumber=0, likeNumber=51, createdTime=2019-05-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=373b1652964b, moduleTitle=Bayer/Orion的非甾体雄激素受体拮抗剂darolutamide治疗前列腺癌获得FDA优先审查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=373b1652964b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511726, encodeId=944a1511e26d9, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Blood：维生素K拮抗剂可影响骨髓微环境及造血, objectType=article, longId=164685, objectId=a9ed164685a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a9ed164685a7, replyNumber=0, likeNumber=124, createdTime=2019-04-22, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a9ed164685a7, moduleTitle=Blood：维生素K拮抗剂可影响骨髓微环境及造血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9ed164685a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511725, encodeId=647f1511e2560, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=GlycoMimetics宣布计划启动乳腺癌试验以评估E-selectin和CXCR4双功能拮抗剂GMI-1359, objectType=article, longId=164225, objectId=4f7b164225a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4f7b164225a4, replyNumber=0, likeNumber=115, createdTime=2019-04-15, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4f7b164225a4, moduleTitle=GlycoMimetics宣布计划启动乳腺癌试验以评估E-selectin和CXCR4双功能拮抗剂GMI-1359, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4f7b164225a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511724, encodeId=0d071511e2457, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Arthritis Rheumatol：使用一线重组白介素-1受体拮抗剂治疗新发全身型幼年特发性关节炎, objectType=article, longId=162191, objectId=f4bf162191b0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4bf162191b0, replyNumber=0, likeNumber=54, createdTime=2019-03-14, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4bf162191b0, moduleTitle=Arthritis Rheumatol：使用一线重组白介素-1受体拮抗剂治疗新发全身型幼年特发性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4bf162191b0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511723, encodeId=c9cd1511e23f7, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Hematology：Denosumab对输血依赖性地中海贫血和骨质疏松症患者血清骨形态发生蛋白拮抗剂noggin的影响, objectType=article, longId=158923, objectId=ebd9158923fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebd9158923fd, replyNumber=0, likeNumber=63, createdTime=2019-01-27, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebd9158923fd, moduleTitle=Hematology：Denosumab对输血依赖性地中海贫血和骨质疏松症患者血清骨形态发生蛋白拮抗剂noggin的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebd9158923fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511722, encodeId=cc6e1511e229d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系, objectType=article, longId=157152, objectId=5a6115e152ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a6115e152ee, replyNumber=0, likeNumber=80, createdTime=2019-01-02, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a6115e152ee, moduleTitle=Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a6115e152ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拮抗剂

2020-05-29

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

BioLineRx宣布其CXCL4拮抗剂BL-8040与Keytruda联合治疗转移性胰腺癌的2b临床活性

2019-11-08

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

头颈癌治疗传捷报：Debiopharm成功完成IAP拮抗剂Debio 1143的II期研究

2019-09-06

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Cell | 解惑！肿瘤坏死因子拮抗剂治疗不明原因肠炎为何经常无效？

2019-09-06

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Lancet：肌松拮抗剂与麻醉后肺部并发症：多中心前瞻性观察研究

2019-09-02

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Sci transl med：MDM2拮抗剂可克服黑色素瘤对CDK4/6抑制剂的耐药性

2019-08-22

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Stroke：亚洲房颤患者非维生素K拮抗剂口服抗凝剂与华法林疗效比较

2019-08-21

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Sci transl med：GHSR1拮抗剂联合DRD1拮抗剂可改善AD病变

2019-08-17

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

卵巢储备功能低下高龄患者微刺激助孕失败后拮抗剂方案成功助孕１例

2019-08-08

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Clin Gastroenterology H：早期启动肿瘤坏死因子拮抗剂治疗克罗恩病比晚期启动相比降低了成本

2019-07-16

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

NEJM：口服降钙素基因相关肽受体拮抗剂Rimegepant治疗偏头痛

2019-07-12

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Int Immunopharmacol：TLR4拮抗剂能够减轻并发过敏性鼻炎和哮喘综合症

2019-06-11

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Blood：口服MDM2蛋白拮抗剂Idasanutlin用于真性红细胞增多症的疗效评估

2019-06-08

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Neurology：β2AR激动剂/拮抗剂与帕金森病的相关性

2019-05-31

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

子宫内膜异位症相关疼痛：GnRH受体拮抗剂linzagolix的II期试验取得成功

2019-05-07

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Bayer/Orion的非甾体雄激素受体拮抗剂darolutamide治疗前列腺癌获得FDA优先审查

2019-05-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Blood：维生素K拮抗剂可影响骨髓微环境及造血

2019-04-22

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

GlycoMimetics宣布计划启动乳腺癌试验以评估E-selectin和CXCR4双功能拮抗剂GMI-1359

2019-04-15

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Arthritis Rheumatol：使用一线重组白介素-1受体拮抗剂治疗新发全身型幼年特发性关节炎

2019-03-14

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Hematology：Denosumab对输血依赖性地中海贫血和骨质疏松症患者血清骨形态发生蛋白拮抗剂noggin的影响

2019-01-27

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Eur Heart J：β受体阻滞剂、钙拮抗剂与稳定性冠状动脉疾病患者死亡率的关系

2019-01-02

科室
- - 订阅+
  - 更多科室
工具
服务